Helping EGFR inhibition to block cancer

Nature Neuroscience 20, 1035 (2017). doi:10.1038/nn.4605 Authors: Rolf Warta & Christel Herold-Mende Effectiveness of EGFR treatment is impaired through an early adaptive response. TNF–JNK–Axl–ERK signaling contributes to this primary resistance to EGFR inhibition and might serve as novel target to improve EGFR inhibition.
Source: Nature Neuroscience - Category: Neuroscience Authors: Tags: News and Views Source Type: research